In a significant shift in United States drug policy and regulation, the Biden administration is planning to reclassify marijuana as a less dangerous drug. The proposed reclassification, led by the U.S. Drug Enforcement Administration (DEA), acknowledges the medical benefits of cannabis and its lower potential for abuse compared to other controlled substances.
The White House Office of Management and Budget is currently reviewing this proposal. If approved, marijuana will be moved from being a Schedule I drug, alongside substances like LSD and heroin, down to a Schedule III classificaiton.
- However, this does not mean that marijuana will become legal for recreational use nationwide.
- Instead, the move would facilitate research and recognize the evolving acceptance of cannabis in the U.S.
Of course, this decision has its critics, but it's worth noting that the change would also impact federal income tax breaks for many cannabis businesses.
Sign up for Kiplinger’s Free E-Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
Biden on marijuana reclassification
Under federal law, marijuana is currently classified as a Schedule I controlled substance, making it illegal to grow, transport, or sell. The Biden proposal would reclassify the substance to Schedule III alongside substances like steroids.
Some critics express concerns about potential side effects and marijuana purportedly being a "gateway drug." Proponents argue that rescheduling marijuana is a step in the right direction, emphasizing the need to align federal policy with the growing acceptance and legalization of cannabis at the state level.
President Biden initially called for a review of federal marijuana laws a couple of years ago, a move paired with efforts to pardon individuals convicted of marijuana possession offenses. Meanwhile, 38 states and the District of Columbia have approved marijuana for medical use. Close to half of U.S. states have approved recreational use.
Cannabis rescheduling 280E tax
Lessening federal regulations concerning marijuana could reduce the tax burden on cannabis businesses. That’s because a significant tax provision cannabis operators in the U.S. deal with is Section 280E of the Internal Revenue Code.
Section 280E restricts cannabis businesses from claiming tax credits and deductions for expenses incurred in their business operations. Businesses cannot deduct expenses associated with the "trafficking" of Schedule I or II substances.
Consequently, Section 280E disallows deductions for many ordinary business expenses of cannabis businesses, like rent and employee compensation, when calculating federal taxable income. This limitation can result in higher tax bills for those businesses. Data show that in 2022, marijuana businesses paid nearly $2 billion more in federal taxes compared to “ordinary businesses.”
State cannabis tax
However, some states have taken steps to alleviate this burden by decoupling from 280E. This means cannabis businesses operating in certain states can deduct certain business expenses on state tax returns.
- For example, Virginia, Massachusetts, Missouri, and Maryland are recent states that have excluded IRC 280E from their tax codes.
- But, according to the cannabis advocacy organization the Marijuana Policy Project, several other states, including but not limited to California, Colorado, Connecticut, New York, and Oregon, have eased state tax restrictions related to 280E.
It’s important to note that not all states have implemented decoupling measures. So, without the DEA marijuana reclassification change, cannabis businesses in those states would remain subject to the full impact of Section 280E on federal and state tax bills.
Biden marijuana proposal: Bottom line
As the DEA moves forward with the regulatory process, which could take some time, stakeholders should monitor any developments.
For example, on May 1, Sen. Cory Booker (D-NJ), Majority Leader Chuck Schumer (D-NY), and U.S. Senate Finance Committee Chairman Ron Wyden (D-Ore.) reintroduced the Cannabis Administration and Opportunity Act. The legislation proposes to end the federal prohibition of cannabis.
In the meantime, cannabis businesses should continue to navigate Section 280E, seeking guidance from qualified tax professionals to optimize tax strategies and ensure compliance with applicable and evolving regulations.
Related
-
4 Things You Need to Know Before Applying for Social Security in 2025Don't unnecessarily delay or reduce your Social Security benefits because you don't know all the rules and requirements.
-
Will Utah Stop Taxing Social Security Benefits?Retirement Taxes Utah Gov. Spencer Cox wants to end the state's tax on Social Security income.
-
Are You a Renter? You Could Save on TaxesTax Breaks With these tax savings at your fingertips, rent may be more affordable
-
2025 Open Enrollment: DACA Recipients Can Purchase Affordable Care Act Health InsuranceOpen Enrollment Over 100,000 people are newly eligible to purchase health insurance from the federal marketplace. Here's what you need to know.
-
Holiday Office Party Taxes: Know Before You GoTax Tips The IRS could tax your gifts from Christmas raffles, Secret Santa, and White Elephant. Here’s how.
-
New Mexico Small Business Saturday Tax Holiday 2024Tax Holiday Here's how you can save on taxes during New Mexico’s Small Business Saturday.
-
Holiday Shopping Tax Tips for Business OwnersTax Deductions Before hitting the sales, businesses should know these key deductions and look out for overspending.
-
NYC Congestion Pricing: Ghost Tax or Necessary Fee?State Taxes Drivers headed to Manhattan’s downtown district will face a new $9 toll in January.
-
Tax Credit vs. Tax Deduction: What’s the Difference?Tax Breaks Your guide to tax deductions and credits, how the IRS treats them differently, and how they impact your tax bill.
-
Premium Tax Credit: Are You Eligible For This Health Insurance Tax Break?Tax Credits The tax credit can help qualifying individuals pay for coverage from the Affordable Care Act’s health insurance marketplace.
